Exosomes and their roles in immune regulation and cancer.

[1]  Hong-Jian Zhu,et al.  Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. , 2015, Seminars in cell & developmental biology.

[2]  J. Barbuto,et al.  Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets , 2015, Front. Immunol..

[3]  S. Lim,et al.  Immunotherapeutic Potential of Extracellular Vesicles , 2014, Front. Immunol..

[4]  L. Mincheva-Nilsson,et al.  Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. , 2014, Seminars in cancer biology.

[5]  T. Whiteside,et al.  Human CD4+CD39+ regulatory T cells produce adenosine upon co‐expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells , 2014, Clinical and experimental immunology.

[6]  T. Whiteside,et al.  Plasma-derived exosomes mediate immune suppression and serve as a biomarker of response to chemotherapy in Acute Myeloid Leukaemia (AML) (TUM7P.945) , 2014, The Journal of Immunology.

[7]  G. Jönsson,et al.  WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells , 2014, Molecular Cancer.

[8]  T. Whiteside,et al.  Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia , 2014, Front. Immunol..

[9]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[10]  P. Crocker,et al.  CD169 mediates the capture of exosomes in spleen and lymph node. , 2014, Blood.

[11]  John W. Chen,et al.  Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. , 2014, ACS nano.

[12]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[13]  Y. Jeon,et al.  Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization , 2013, BMC Cancer.

[14]  S. Lim,et al.  Exosomes for drug delivery - a novel application for the mesenchymal stem cell. , 2013, Biotechnology advances.

[15]  M. Chopp,et al.  Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  H. Gunawardena,et al.  Modulation of B-cell exosome proteins by gamma herpesvirus infection , 2013, Proceedings of the National Academy of Sciences.

[17]  S. Gabrielsson,et al.  Cancer immunotherapy with exosomes requires B-cell activation , 2013, Oncoimmunology.

[18]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[19]  T. Whiteside.  Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). , 2013, Biochemical Society transactions.

[20]  F. Sánchez‐Madrid,et al.  Transfer of extracellular vesicles during immune cell‐cell interactions , 2013, Immunological reviews.

[21]  Veronica Huber,et al.  Recent advances on the role of tumor exosomes in immunosuppression and disease progression. , 2012, Seminars in cancer biology.

[22]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[23]  Xuetao Cao,et al.  Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway , 2012, The Journal of Immunology.

[24]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[25]  E. N. Nolte-‘t Hoen,et al.  CD4+ T cell activation promotes the differential release of distinct populations of nanosized vesicles , 2012, Journal of extracellular vesicles.

[26]  C. Théry,et al.  Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.

[27]  T. Whiteside,et al.  Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1 , 2011, Haematologica.

[28]  Clotilde Théry,et al.  Exosomes: immune properties and potential clinical implementations , 2011, Seminars in Immunopathology.

[29]  M. Oppermann,et al.  Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3 , 2011, Proceedings of the National Academy of Sciences.

[30]  G. Camussi,et al.  Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. , 2011, Cancer research.

[31]  M. Mason,et al.  Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production , 2011, The Journal of Immunology.

[32]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[33]  S. Wickline,et al.  Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.

[34]  Fátima Sánchez-Cabo,et al.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.

[35]  Gunther Hartmann,et al.  SiRNA delivery with exosome nanoparticles , 2011, Nature Biotechnology.

[36]  J. Yewdell,et al.  Immunology: Cross-dressers turn on T cells , 2011, Nature.

[37]  M. Bevan,et al.  Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection , 2011, Nature.

[38]  R. Schreiber,et al.  Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.

[39]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[40]  U. Welsch,et al.  Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC , 2011, Cancer Immunology, Immunotherapy.

[41]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[42]  Federica Cavallo,et al.  2011: the immune hallmarks of cancer , 2011, Cancer Immunology, Immunotherapy.

[43]  W. Grizzle,et al.  Exosomes and Cancer: A Newly Described Pathway of Immune Suppression , 2011, Clinical Cancer Research.

[44]  M. Mason,et al.  Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.

[45]  Alexander M Seifalian,et al.  The application of exosomes as a nanoscale cancer vaccine , 2010, International journal of nanomedicine.

[46]  N. Raab-Traub,et al.  Human tumor virus utilizes exosomes for intercellular communication , 2010, Proceedings of the National Academy of Sciences.

[47]  J. Xiang,et al.  Dendritic Cells Recruit T Cell Exosomes via Exosomal LFA-1 Leading to Inhibition of CD8+ CTL Responses through Downregulation of Peptide/MHC Class I and Fas Ligand-Mediated Cytotoxicity , 2010, The Journal of Immunology.

[48]  S. Gabrielsson,et al.  Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis , 2010, Thorax.

[49]  P. Anand.  Exosomal membrane molecules are potent immune response modulators , 2010, Communicative & integrative biology.

[50]  T. Whiteside,et al.  Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg) , 2010, PloS one.

[51]  Qiang Zhou,et al.  Cellular Internalization of Exosomes Occurs Through Phagocytosis , 2010, Traffic.

[52]  W. Grizzle,et al.  Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. , 2010, The American journal of pathology.

[53]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[54]  L. Zitvogel,et al.  Dendritic cell-derived exosomes for cancer immunotherapy: what's next? , 2010, Cancer research.

[55]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[56]  M. Vidal,et al.  Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages. , 2010, Blood.

[57]  J. Skepper,et al.  Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. , 2010, Cancer research.

[58]  Samuel A Wickline,et al.  Paracrine induction of endothelium by tumor exosomes , 2009, Laboratory Investigation.

[59]  T. Ravikumar,et al.  Immature Dendritic Cell-Derived Exosomes Rescue Septic Animals Via Milk Fat Globule Epidermal Growth Factor VIII , 2009, The Journal of Immunology.

[60]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[61]  Carmen Visus,et al.  Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes1 , 2009, The Journal of Immunology.

[62]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[63]  B. Rothen‐Rutishauser,et al.  Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway. , 2009, The American journal of pathology.

[64]  L. Mincheva-Nilsson,et al.  Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function1 , 2009, The Journal of Immunology.

[65]  A. Poliakov,et al.  Induction of myeloid‐derived suppressor cells by tumor exosomes , 2009, International journal of cancer.

[66]  Robert L Moritz,et al.  Exosomes: proteomic insights and diagnostic potential , 2009, Expert review of proteomics.

[67]  D. Bigner,et al.  Proteomic and immunologic analyses of brain tumor exosomes , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  Laurence Zitvogel,et al.  Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα , 2009, PloS one.

[69]  C. Kim,et al.  MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. , 2009, Cancer letters.

[70]  T. Niki,et al.  Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. , 2009, Blood.

[71]  C. Théry,et al.  No Significant CTL Cross-Priming by Dendritic Cell-Derived Exosomes during Murine Lymphocytic Choriomeningitis Virus Infection1 , 2009, The Journal of Immunology.

[72]  F. Guo,et al.  Anti-Tumour Effects of Exosomes in Combination with Cyclophosphamide and Polyinosinic–Polycytidylic Acid , 2008, The Journal of international medical research.

[73]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[74]  M. Koike,et al.  Human Herpesvirus-6 Induces MVB Formation, and Virus Egress Occurs by an Exosomal Release Pathway , 2008, Traffic.

[75]  S. Kaushal,et al.  Exosomes as a tumor immune escape mechanism: possible therapeutic implications , 2008, Journal of Translational Medicine.

[76]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[77]  M. Mason,et al.  Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1 , 2008, The Journal of Immunology.

[78]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[79]  C. Steinem,et al.  Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages1 , 2008, The Journal of Immunology.

[80]  Simon C Watkins,et al.  Exosomes As a Short-Range Mechanism to Spread Alloantigen between Dendritic Cells during T Cell Allorecognition1 , 2008, The Journal of Immunology.

[81]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[82]  S. Ostrand-Rosenberg,et al.  Immune surveillance: a balance between protumor and antitumor immunity. , 2008, Current opinion in genetics & development.

[83]  Yue-cheng Yu,et al.  Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived from Umbilical Cord Blood for Immunotherapy Treatment , 2008, Clinical medicine. Oncology.

[84]  S. Nagata,et al.  Identification of Tim4 as a phosphatidylserine receptor , 2007, Nature.

[85]  F. Castellino,et al.  Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. , 2007, Blood.

[86]  A. Muntasell,et al.  T cell‐induced secretion of MHC class II–peptide complexes on B cell exosomes , 2007, The EMBO journal.

[87]  S. Ceccarelli,et al.  Epstein‐Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes , 2007, International journal of cancer.

[88]  Sanchita Bhatnagar,et al.  Exosomes Released from Infected Macrophages Contain Mycobacterium avium Glycopeptidolipids and Are Proinflammatory* , 2007, Journal of Biological Chemistry.

[89]  Aled Clayton,et al.  Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. , 2007, Cancer research.

[90]  Riitta Lahesmaa,et al.  Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.

[91]  B. Sander,et al.  Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. , 2007, Free radical biology & medicine.

[92]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[93]  K. Poh,et al.  Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy. , 2007, International journal of cardiology.

[94]  G. Raposo,et al.  T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. , 2007, Gastroenterology.

[95]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[96]  Jim Xiang,et al.  Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity , 2007, Immunology.

[97]  M. Hirashima,et al.  Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9 , 2006, BMC Cancer.

[98]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[99]  A. Villa,et al.  Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. , 2006, Cancer research.

[100]  M. Zöller,et al.  Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. , 2006, Cancer research.

[101]  S. Gabrielsson,et al.  Direct exosome stimulation of peripheral humanT cells detected by ELISPOT , 2006, European journal of immunology.

[102]  K. Renaudin,et al.  Induction of Tolerance by Exosomes and Short‐Term Immunosuppression in a Fully MHC‐Mismatched Rat Cardiac Allograft Model , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[103]  M. Gottesman,et al.  Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[104]  W. Grizzle,et al.  A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death1 , 2006, The Journal of Immunology.

[105]  J. Xiang,et al.  Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. , 2006, Cellular & molecular immunology.

[106]  Xuetao Cao,et al.  Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells , 2006, European journal of immunology.

[107]  L. Zitvogel,et al.  Prospects for exosomes in immunotherapy of cancer , 2006, Journal of cellular and molecular medicine.

[108]  L. Zitvogel,et al.  Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines1 , 2006, The Journal of Immunology.

[109]  T. Whiteside,et al.  Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. , 2006, Seminars in cancer biology.

[110]  William E. Grizzle,et al.  Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1 , 2006, The Journal of Immunology.

[111]  Taoyong Chen,et al.  More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells , 2005, Clinical Cancer Research.

[112]  B. Quah,et al.  The immunogenicity of dendritic cell-derived exosomes. , 2005, Blood cells, molecules & diseases.

[113]  J. Chin,et al.  Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis , 2005 .

[114]  C. Théry,et al.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.

[115]  C. Gross,et al.  Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. , 2005, Cancer research.

[116]  G. Parmiani,et al.  Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. , 2005, Gastroenterology.

[117]  J. Le Pecq,et al.  Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature’s antigen delivery pathway , 2005, Expert review of anticancer therapy.

[118]  Bart N Lambrecht,et al.  Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. , 2005, American journal of respiratory and critical care medicine.

[119]  A. Clayton,et al.  Exosomes and the MICA-NKG2D system in cancer. , 2005, Blood cells, molecules & diseases.

[120]  Jung-Ah Cho,et al.  Exosomes: A new delivery system for tumor antigens in cancer immunotherapy , 2005, International journal of cancer.

[121]  M. Mason,et al.  The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. , 2005, Vaccine.

[122]  Simon C Watkins,et al.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[123]  T. Whiteside,et al.  Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? , 2005, British Journal of Cancer.

[124]  F. Lozupone,et al.  Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. , 2004, Journal of the National Cancer Institute.

[125]  Simon C Watkins,et al.  Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. , 2004, Blood.

[126]  B. Beutler,et al.  The interface between innate and adaptive immunity , 2004, Nature Immunology.

[127]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[128]  Aled Clayton,et al.  Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[129]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[130]  T. Godfrey,et al.  Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. , 2004, Clinical chemistry.

[131]  E. Tomaskovic-Crook,et al.  Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice , 2003, Gut.

[132]  T. Whiteside,et al.  T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[133]  C. Hotta,et al.  MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. , 2003, Immunology letters.

[134]  Aled Clayton,et al.  Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.

[135]  C. Théry,et al.  Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes , 2002, Nature Immunology.

[136]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[137]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.

[138]  P. Benaroch,et al.  Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. , 2002, International immunology.

[139]  Veronica Huber,et al.  Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles , 2002, The Journal of experimental medicine.

[140]  Keiko Miwa,et al.  Identification of a factor that links apoptotic cells to phagocytes , 2002, Nature.

[141]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[142]  M. Martínez-Lorenzo,et al.  Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1 , 2001, The Journal of Immunology.

[143]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[144]  E. Bloemena,et al.  Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1 , 2000, The Journal of Immunology.

[145]  Laurence Zitvogel,et al.  Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.

[146]  M. Martínez-Lorenzo,et al.  Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.

[147]  H. Auchincloss,et al.  Direct and indirect recognition: the role of MHC antigens in graft rejection. , 1999, Immunology today.

[148]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[149]  K. Rock,et al.  Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. , 1996, Journal of immunology.

[150]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[151]  D. Taylor,et al.  Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages. , 1985, Journal of immunology.

[152]  P. Novick,et al.  Role of Rab GTPases in membrane traffic and cell physiology. , 2011, Physiological reviews.

[153]  M. Zöller.  Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.

[154]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[155]  L. Zitvogel,et al.  Exosomes for cancer immunotherapy. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[156]  L. Zitvogel,et al.  Exosomes for immunotherapy of cancer. , 2003, Advances in experimental medicine and biology.

[157]  L. Zitvogel,et al.  Exosomes in cancer immunotherapy: preclinical data. , 2001, Advances in experimental medicine and biology.

[158]  S. Amigorena.  Cancer immunotherapy using dendritic cell-derived exosomes. , 2000, Medicina.